Moreover, it had been found that Survivin expression was elevated in tumor tissues of chemotherapy-resistant osteosarcoma patients, and that continued chemotherapy could mediate the enrichment of high Survivin-expressing osteosarcoma cells, which ultimately lead to the development of multidrug resistance in the clinic (Wei et al., 2021). This evidence concerns the gene BIRC5 and neoplasm.